openPR Logo
Press release

Global Dengue Vaccine Market Revenue Is Expected To Expand At A Significant Rate Owing To A Large Unmet Need

Global Dengue Vaccine Market Revenue Is Expected To Expand At

Burdening occurrence of dengue fever across the Asia-Pacific region has prompted the demand for effective vaccines and medications to supress this viral malaise. While several pharmaceutical companies are striving to develop a cure for dengue, the fever’s incidence rate in Asia-Pacific is rising at an alarming rate. A recent report published by Future Market Insights predicts that in 2017, an estimated 70.3% of global dengue vaccines market will be dominated by Asia-Pacific. Through 2027, the region will continue to be the largest market for dengue vaccines, procuring a majority revenue share and projecting revenue growth at a 17.4% CAGR.

Request to Sample Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-1763

Future Market Insights also observes Latin America as the second-largest market for dengue vaccines, and is expected to rake in US$ 288.7 Mn towards the end of 2027. The report, titled “Dengue Vaccines Market: Global Industry Analysis and Opportunity Assessment, 2017-2027,” expects that more and more pharmaceutical giants from across the globe will be partaking in the market’s growth in the years to come. Currently, the market is witnessing active participation of French drugmaker, Sanofi S.A., while vaccines being formulated by companies such as Biological E. Limited, Takeda Pharmaceutical Company Limited, GlaxoSmithKline plc, Merck & Co. Inc., Vabiotech, Butantan Institute, and Panacea Biotech Ltd. are under multiple phases of development.

The report further reveals that government institutes will remain the largest end-users of dengue vaccines in the world. Through 2027, a little less than US$ 650 Mn worth of revenues is expected to arise from sales of dengue vaccines across government institutes. Meanwhile, hospitals will also dominate the market by registering a 17.3% revenue CAGR. The market, at present, will witness sales of the sole of vaccine, Dengvaxia, developed by Sanofi. Furthermore, factors shaping up the dynamics of global dengue vaccines market, also compiled in the report, are:

Apart from the burdening outbreak of dengue in several countries, the economic turmoil in Latin America is projected to impact the global market’s growth at a macroeconomic level

Live attenuated vaccines are being developed & produced economically, thereby comforting vaccine makers as well as patients

However, lack of skilled professionals and unavailability of optimum diagnostic systems has given rise to cases where dengue fever is being treated as an undistinguished febrile disease

The global market for dengue vaccines holds an opportunistic breakthrough when drugmakers will be able to successfully develop effective vaccines for all age group

Request Report TOC @ https://www.futuremarketinsights.com/askus/rep-gb-1763

ABOUT US:
Future Market Insights (FMI) is a leading market intelligence and consulting firm. We deliver syndicated research reports, custom research reports and consulting services, which are personalized in nature. FMI delivers a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights, an aerial view of the competitive framework, and future market trends.

CONTACT:
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
F: +1-845-579-5705
Email: sales@futuremarketinsights.com
Website :www.futuremarketinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Dengue Vaccine Market Revenue Is Expected To Expand At A Significant Rate Owing To A Large Unmet Need here

News-ID: 1060331 • Views:

More Releases from Future Market Insights - MRRSE

Reshaping the Culinary Landscape: Insights into the Used Commercial Kitchen Equipment Market's Journey to 2033
Reshaping the Culinary Landscape: Insights into the Used Commercial Kitchen Equi …
The forecast term is expected to see a moderately paced CAGR of 7.2% for the global market for secondhand restaurant equipment. The market for used restaurant equipment is expected to be worth US$ 6664.2 Million in 2023. By 2033, it is expected that the market for used restaurant equipment will have grown to a high of US$ 13356.6 million. The specialists at Future Market Insights have calculated a historical CAGR
Poland IT Software and Service Market Size: Competitive Landscape and Recent Ind …
Future Market Insights (FMI) released its latest report titled, “Poland IT Software and Service Market Forecast and Assessment, 2014 – 2020”. According to the report, the Poland IT software and service market was valued at US$ 4,104.3 Mn in 2013 and projected to reach US$ 6,245.8 Mn by 2020, registering a CAGR of 5.9% during the forecast period. The Poland IT software and service market is driven by factors such as
Plant-based Butter Market to exhibit CAGR exceeding 7.5% through 2030 – Exclusive Report by FMI
Plant-based Butter Market to exhibit CAGR exceeding 7.5% through 2030 – Exclus …
Sales of vegan foods and beverages have gone up significantly owing to increased health awareness among consumers, especially in terms of effects from the consumption of animal-based products. The broader gains in the plant-based food category have rubbed off on varied categories, with plant-based butter sales gaining significant traction. The growing popularity of plant-based butter has led to specialty brands experimenting with new flavors and sources. A new study by
Conference Room Solutions Market Worth US$ 1.18 Bn by 2021: FMI
Conference Room Solutions Market Worth US$ 1.18 Bn by 2021: FMI
As per the revised report by Future Market Insights (FMI), the global conference room solution market is expected to expand at a CAGR of 14.7% over the forecast period (2021-2031). Thanks to rising demand for improvement in enterprise communication network, the market valuation is expected to surpass US$ 1.18 Bn in 2021. Conference room solutions provide on-demand tools for professional collaboration, online meetings, web conferencing and video conferencing services. It supports

All 5 Releases


More Releases for Dengue

Key Trend Reshaping the Dengue Treatment Market in 2025: Innovative Drug Deliver …
Which drivers are expected to have the greatest impact on the over the dengue treatment market's growth? The escalation in cases of dengue is projected to stimulate the expansion of the market for dengue treatments. Dengue is a viral infection transmitted by mosquito bites, causing symptoms akin to the flu and can escalate to intense complications if not treated. The escalation is primarily due to progressing urbanization, climate alterations favourable to
Key Dengue Vaccine Market Trend for 2025-2034: Advancements In Dengue Tetravalen …
What Is the Future Outlook for the Dengue Vaccine Market's Size and Growth Rate? In the past few years, the dengue vaccine market has experienced significant growth. From $0.64 billion in 2024, it is projected to reach $0.72 billion in 2025, marking a compound annual growth rate (CAGR) of 12.4%. This notable expansion during the historical period can be credited to factors such as an increase in travel and urbanization trends,
Dengue Vaccine Market : An Detailed Overview
Introduction: Dengue fever is a mosquito-borne viral infection caused by the dengue virus, transmitted primarily through Aedes aegypti and Aedes albopictus mosquitoes. Affecting millions globally each year, dengue has become a significant public health concern, especially in tropical and subtropical regions. The development of dengue vaccines represents a groundbreaking advancement in preventing the disease, reducing its associated healthcare costs, and controlling outbreaks. With increasing awareness and investments in immunization programs, the
Dengue Vaccine Market : An Overview
Introduction: Dengue fever is a mosquito-borne viral infection that has become a significant public health challenge in tropical and subtropical regions. The disease is caused by the dengue virus, which is transmitted primarily by Aedes aegypti mosquitoes. With approximately 390 million infections annually, dengue fever places a substantial burden on healthcare systems and economies worldwide. Efforts to mitigate this burden have led to the development of dengue vaccines, designed to prevent
"Rising Incidence of Dengue Fever Propels Dengue Virus Diagnostic Tests Market T …
According to WHO, dengue affects about 50-100 million people worldwide, annually. It is a vector-borne highly communicable disease. This report discusses the diagnostic tests used to confirm the presence of dengue in one individual. It is true that the growth of the global dengue virus diagnostic tests market is primarily driven by an increase in the incidence of dengue fever, which is a mosquito-borne viral infection that can cause severe flu-like
Dengue Vaccines Market 2021 | Detailed Report
Dengue Vaccines Market Forecasts report provided to identify significant trends, drivers, influence factors in global and regions, agreements, new product launches and acquisitions, Analysis, market drivers, opportunities and challenges, risks in the market, cost and forecasts to 2027. Get Free Sample PDF (including full TOC, Tables and Figures) of Dengue Vaccines Market @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=4644240 The report provides a comprehensive analysis of company profiles listed below: - Sanofi - Takeda Dengue Vaccines Market Segment by